Main Article Content
Bleomycin is an anti-neoplastic drug that has recently been used for the treatment of vascular anomalies. An expedient method was developed for the determination of plasma bleomycin levels using ion-paired reversed phase high performance liquid chromatography (HPLC). The concentration was found to be proportional to the area and the response of the detector was determined to be linear over the range of 1-6 Âµg/ml for both Bleomycin A1 and Bleomycin B2. Recovery was approximately 100%. This method provides a simple and rapid way of determining the levels of bleomycin A2 and B2 in human and rat plasma
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copyright of the published manuscript lies with the author. In submitting an article to Journal of Applied Pharmaceutical Research (JOAPR) I certify that:
- I am authorized by my co-authors to enter into these arrangements.
- I warrant, on behalf of myself and my co-authors, that:
- the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
- I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JOAPR are not in breach of any other obligation;
- the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
- I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.
- I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution-NonCommercial 4.0 International License
- I, and all co-authors, agree that, if the article is editorially accepted for publication in Journal of Applied Pharmaceutical Research (JOAPR) data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.
- I, and all co-authors are permitted and encouraged to post my/our work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
 Kirthi A, Shanmugam R, Prathyusha SM, Basha J. A review on bioanalytical method development and validation by RP-HPLC. Journal of Global Trends in Pharmaceutical Sciences, 5, 2265–71 (2014).
 Abraham AT, Lin J, Newton DL, Rybak S, Hecht SM. RNA cleavage and inhibition of protein synthesis by bleomycin. Chemical & Biology, 10, 45–52 (2003).
 Blanchet B, Saboureau C, Benichou AS, Billemont B, Taieb F, Ropert S, Dauphin A, Goldwasser F, Tod M. Development and validation of an HPLC-UV-visible method for sunitinib quantification in human plasma. Clinica Chimica Acta, 404, 134–9 (2009).
 Burger RM, Peisach J, Horwitz SB. Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA. Journal of Biological Chemistry, 256, 11636–44 (1981).
 Carter BJ, de Vroom E, Long EC, van der Marel G a, van Boom JH, Hecht SM. Site-specific cleavage of RNA by Fe(II).bleomycin. Proceedings of the National Academy of Sciences of the United States of America, 87, 9373–7 (1990).
 Chan CC, Leo YC, Lam H. Analytical method validation and Instrument Perfomance Validation.Vol-I, Wiley Interscince, USA.2004
 Chan ECY, Wee PY, Ho PC. The value of analytical assays that are stability-indicating. Clinica Chimica Acta, 288, 47–53 (1999).
 Chen J, Stubbe J. Bleomycins: New methods will allow reinvestigation of old issues. Current Opinion in Chemical Biology, 8, 175–81 (2004).
 Chitturi SR, Bharathi C, Reddy AVR, Reddy KC, Sharma HK, Handa VK, Dandala R, Bindu VH. Impurity profile study of lopinavir and validation of HPLC method for the determination of related substances in lopinavir drug substance. Journal of Pharmaceutical and Biomedical Analysis, 48, 1430–40 (2008).
 Chmielewska A, Konieczna L, Plenis A, Lamparczyk H. Quantitative Determination of Pentoxifylline in Human Plasma. Acta Chromatographica, 16, 70–9 (2006).
 Collier JW, Shah RB, Bryant AR, Habib MJ, Khan MA, Faustino PJ. Development and application of a validated HPLC method for the analysis of dissolution samples of levothyroxine sodium drug products. Journal of Pharmaceutical and Biomedical Analysis, 54, 433–8 (2011).
 Sridharan D, Thenmozhi A, Sundaranandavalli S. Article Article Bioanalytical Method Development and Validation of Atenolol in Human Plasma By Lc Ms. Asian Journal of Pharmaceutical and Clinical Research, 3, 92–4 (2010).